Just a week out from losing its CEO, Teva Pharmaceutical Industries Ltd. needed to report annual results from a tough year and face tough questions about the company’s direction. And while management noted that a full review was taking place, most of those questions will remain unanswered until a new CEO is in place.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?